Liver Cancer Treatment
Advanced minimally invasive liver cancer treatment with TACE, cryotherapy, and immunotherapy. 85%+ success rate for early-stage cases.
This information is for educational purposes only and does not constitute medical advice. Individual treatment plans vary.
Overview
Liver cancer (hepatocellular carcinoma) is one of the most common cancers among Bangladeshi patients seeking treatment in China. Modern Cancer Hospital Guangzhou offers world-class minimally invasive treatments including TACE, cryotherapy, and combined immunotherapy with success rates over 85% for early-stage cases. Our integrated approach combines cutting-edge technology with traditional Chinese medicine support.
Common Symptoms
- Unexplained weight loss
- Loss of appetite
- Upper abdominal pain
- Nausea and vomiting
- General weakness and fatigue
- Abdominal swelling (ascites)
- Yellowing of skin and eyes (jaundice)
- White, chalky stools
Diagnosis Methods
- Alpha-fetoprotein (AFP) blood test
- CT scan with contrast
- MRI of the liver
- PET-CT scan
- Liver biopsy
- Hepatitis B/C testing
- Liver function tests
Treatment Options
Transarterial Chemoembolization (TACE)
Cryoablation (Argon-Helium)
Radiofrequency Ablation (RFA)
Microwave Ablation
Particle Implantation (Iodine-125 seeds)
Targeted Therapy
Combined Immunotherapy (PD-1 + TACE)
Surgical Resection
Quick Info
Timeline
Initial evaluation: 2-3 days. Treatment planning: 1-2 days. TACE procedure: 1-2 hours. Hospital stay: 3-5 days per session. Multiple sessions may be needed 4-6 weeks apart. Total stay: 2-4 weeks depending on treatment plan.
Free Evaluation
Submit your reports for assessment